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Abstract: Regular walnut consumption is associated with better health. We have previously shown
that eight weeks of walnut consumption (43 g/day) significantly improves lipids in healthy subjects.
In the same study, gut microbiome was evaluated. We included 194 healthy subjects (134 females,
63 ± 7 years, BMI 25.1 ± 4.0 kg/m2) in a randomized, controlled, prospective, cross-over study.
Following a nut-free run-in period, subjects were randomized to two diet phases (eight weeks each);
96 subjects first followed a walnut-enriched diet (43 g/day) and then switched to a nut-free diet, while
98 subjects followed the diets in reverse order. While consuming the walnut-enriched diet, subjects
were advised to either reduce fat or carbohydrates or both to account for the additional calories.
Fecal samples were collected from 135 subjects at the end of the walnut-diet and the control-diet
period for microbiome analyses. The 16S rRNA gene sequencing data was clustered with a 97%
similarity into Operational Taxonomic Units (OTUs). UniFrac distances were used to determine
diversity between groups. Differential abundance was evaluated using the Kruskal–Wallis rank sum
test. All analyses were performed using Rhea. Generalized UniFrac distance shows that walnut
consumption significantly affects microbiome composition and diversity. Multidimensional scaling
(metric and non-metric) indicates dissimilarities of approximately 5% between walnut and control
(p = 0.02). The abundance of Ruminococcaceae and Bifidobacteria increased significantly (p < 0.02)
while Clostridium sp. cluster XIVa species (Blautia; Anaerostipes) decreased significantly (p < 0.05)
during walnut consumption. The effect of walnut consumption on the microbiome only marginally
depended on whether subjects replaced fat, carbohydrates or both while on walnuts. Daily intake
of 43 g walnuts over eight weeks significantly affects the gut microbiome by enhancing probiotic-
and butyric acid-producing species in healthy individuals. Further evaluation is required to establish
whether these changes are preserved during longer walnut consumption and how these are linked to
the observed changes in lipid metabolism.
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1. Introduction
The human gut microbiome encompasses approximately 1014 resident microorganisms, mainly
consisting of bacteria, and corresponds to 1000 distinct species with a collective genome containing at
least 100 times as many genes as the human genome [1]. The establishment of high-throughput
sequencing allows the metagenome to be studied for broad analyses of intestinal microbiota
composition [2]. These microbial communities contribute to host health through various functions
including probiotic properties, biosynthesis of vitamins and essential amino acids, as well as production
of metabolic byproducts from indigestible dietary constituents. Butyrate, a short chain fatty acid
which is produced by bacterial fermentation of non-digestible carbohydrates in the colon, acts as a
major energy source for intestinal epithelial cells, enhances intestinal epithelial barrier function and
modulates immune function [3,4].
The fact that there is considerable variation in the constituents of the gut microbiota among
apparently healthy individuals strengthened the hypothesis that there is a clear link between health,
disease and diversity of the human gut microbiome. Indeed, a dysbiosis of the gut microbiota
is associated with the pathogenesis of both intestinal and extra-intestinal disorders including
inflammatory bowel disease, metabolic diseases such as obesity and diabetes mellitus type 2, and
cardiovascular diseases [5]. The impact of environmental factors, including aspects of lifestyle or
drug therapy on the microbiota is of major clinical interest. Diet is one of the main determinants of
the microbial composition in the gut influencing diversity, distribution and abundance of microbial
populations from the early stages of life [6]. Indeed, diet changes are thought to explain 57% of the
total structural variation in the gut microbiota [7]. An acute change in diet has been shown to alter
microbial composition within just 24 h of initiation (e.g., switching to a completely plant-based diet),
with reversion to baseline within approximately 48 h of diet discontinuation [8]. According to this,
there is growing interest in modifying the gut microbiota for long-term health benefits.
The microbiome analysis was part of our previously published study in which we investigated
the effect of regular walnut consumption (43 g/day) on the lipid profile in healthy subjects, resulting
in a significant reduction of LDL-cholesterol, apoB, triglycerides and non-HDL-cholesterol after eight
weeks of intervention [9]. Evidence from recent animal and human feeding studies shows a correlation
between regular nut consumption and a shift within the gut microbiome, indicating prebiotic properties
of members of the tree nut family. However, the exact mechanisms by which nuts offer their prebiotic
effects on microbial diversity is not fully understood [10,11]. Another issue to be addressed is, how
these changes might be associated with the observed changes in lipid metabolism.
The aim of this sub study was to investigate the effect of walnut consumption on the gut
microbiome composition and microbial diversity.
2. Materials and Methods
2.1. Study Design
The study comprises a randomized, controlled, prospective, cross-over design as previously
described [9]. Each subject followed a nut-free Western-type diet consisting of 50% carbohydrates,
35% fat (15% saturated fat), and 15% protein during a 4-week run-in period. Thereafter, subjects were
randomized to 2 different diet phases, each lasting for 8 weeks (separated by a 4-week washout). One
group (n = 96) first followed a walnut-enriched diet (43 g of shelled walnuts/day) and then switched
to a nut-free control diet. The other group (n = 98) followed the diets in reverse order (Figure 1). Study
duration was 6 months (24 weeks) for each study subject. During the walnut diet the subjects were
randomized into three different diet groups, in which they were advised to reduce the intake of either
carbohydrates (CH, n = 62; 44 with stool samples), fat (n = 65; 47 with stool samples), or both (n = 67;
46 with stool samples). They were instructed to replace either 70 g carbohydrates or 30 g of (saturated)
fat with the walnuts. Subjects assigned to the third group were advised to replace both macronutrients
(35 g carbohydrates and 15 g fat) with the daily walnut serving. These recommendations were food
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based, i.e., on the basis of individual food reports (free text), a nutritionist recommended specific
measures to adjust the diet. Stool samples were collected at the end of each diet phase.
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Samples were immediately frozen at −20 °C, transported on dry ice and then stored at −80 °C until 
further analysis. 
Figure 1. Flowchart of study subjects. In total, 204 subjects were randomized. 142 subjects were
included in stool analysis. 7 subjects were excluded due to antibiotic therapy. In total, stool samples
from 135 study subjects were included in statistical evaluation. CH: carbohydrate restriction; F: fat
restriction; Comb: combined carbohydrate and fat restriction.
2.2. Study Subjects
Study participants (n = 204) were healthy Caucasian men and postmenopausal women older than
50 years (134 females and 60 males, age 63 ± 7 years, BMI 25.1 ± 4.0 kg/m2) [9]. We included healthy
non-smoking subjects older than 50 years (men and postmenopausal women) with LDL-C < 190 mg/dL,
triglycerides (TG) < 350 mg/dL, and a body mass index (BMI) < 35 kg/m2. We excluded persons with a
history of cardiovascular and atherosclerotic disease, a known allergy to tree nuts, a vegan or ovo-lacto
vegetarian lifestyle, and patients on regular medication (except stable treatment of thyroid disease and
hypertension). Stool samples were only available in 142 of the original 204 subjects. Further 7 study
subjects were subsequently excluded due to antibiotic therapy. In total, 270 stool samples (2 samples
from each of the 135 study subject) were analyzed.
2.3. Stool Sample Collection
Subjects were instructed to collect stool samples within 24 h before the next study visit and
refrigerate them until the visit. The required materials for a hygienically safe stool collection were
provided by the study center. The study kit comprised disposable gloves, a sample-catching paper
(Süsse Labortechnik MED AUXIL 150 × 470 mm #S1000), sample-collecting tubes including 8 mL of
stool DNA stabilizer (str t c molecular #1038111100), transport bags, as w ll as instructions for use
and a qu stionna re (Bristol Stool Chart) for recording sampling conditions and sample quality [12].
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Samples were immediately frozen at −20 ◦C, transported on dry ice and then stored at −80 ◦C until
further analysis.
2.4. Sample Processing and Sequencing
The identification and comparison of microbial communities was evaluated by using
high-throughput sequencing of the V3/V4 region of the 16S rRNA gene [2]. The method is based on
the isolation of genomic DNA and its duplication produced by Polymerase Chain Reaction (PCR),
followed by sequencing of the PCR amplicon by using a specific primer that binds to highly conserved
sequences on the 16S rRNA gene [13]. Sample processing has been divided into DNA isolation,
library construction by PCR, amplicon cleaning and dilution, and sequencing. DNA was isolated
with a modification of the protocol by Godon et al. [14]. After isolation, DNA was purified using a
silica-membrane based NucleoSpin gDNA Clean-up Kit (REF 740230.250 Machery-Nagel). The PCR
was performed in duplicate and the PCR products of duplicates were pooled prior to cleaning [13].
For quality control, a selection of samples was analyzed by electrophoresis. PCR purification was
performed by using AGENCOURT AMPure XP Beads (Beckman Coulter, Brea, CA, USA). The 16S
rRNA gene amplicon libraries were sequenced in paired-end modus using an Illumina MiSeq.
2.5. Data Analysis
The resulting dataset was processed through taxonomic classification against a database of
reference 16S rRNA gene sequences. After sequencing, raw data reads were assigned to their
corresponding sample via demultiplexing using previously assigned barcode pairs which are unique
for each sample. The demultiplexing was performed by using an in-house developed Perl script. After
demultiplexing, data were analyzed using the IMNGS platform (www.imngs.org), which is based on
the UPARSE approach for sequence quality check, chimera filtering, and cluster formation [15]. Output
was an Operational Taxonomic Units (OTU) analysis calculating and visualizing the relative abundance
of the bacterial taxa present in each sample. For quantifying alpha-diversity, the intra-sample variation
is calculated. Richness gives the value of present OTUs within one sample while the diversity index
estimates the number of equal species within one sample. Simpson effective counts out more weight
on dominant species while Shannon is based on richness and evenness. To avoid incorrect estimation
of species richness due to differential sequencing depth, only normalized counts that are above 0.5
were considered. Based on an OTU threshold of 97% similarity, UniFrac distances (a distance metric
for microbial community comparison) were calculated to evaluate beta-diversity (diversity between
the samples). Beta-diversity was determined by Principal Coordinate Analysis (PCoA) using both
unweighted and weighted UniFrac metrices. Metric Multidimensional Scaling (MDS) and non-metric
multidimensional scaling (NMDS) projections of the generalized UniFrac distances were produced
and a PERMANOVA test was performed to determine statistical significant differences. Differential
abundance was evaluated performing the Kruskal–Wallis rank sum test. To determine differences
between groups, based on the relative abundance of occurring OTUs, a non-parametric ANOVA
(Kruskal–Wallis rank sum test) was applied. Significant differences based on prevalences between
groups are calculated by Fisher exact test. For downstream processing of intermediate files generated by
IMNGS, a fully modular R-based pipeline (Rhea) was developed for analysis of microbial profiles [16].
Statistical significance was set at p ≤ 0.05. Any p-values less than 0.05 are shown.
2.6. Ethics Statement
The Study was conducted according to the guidelines in the Declaration of Helsinki and the
ICH Harmonized Tripartite Guideline for Good Clinical Practice. The study protocol was approved
by the ethics committee of the Faculty of Medicine of the University of Munich. After informing
subjects about the study, the intervention, and side effects, all study participants provided written
informed consent. The study was registered at ClinicalTrials.gov (NCT02329067) and performed
between February 2015 and May 2016 at the University of Munich Medical Center. Walnuts were
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provided by the California Walnut Commission (Folsom, CA, USA). Sample analysis was performed
at the Chair of Nutrition and Immunology (Core Facility Microbiome) of the Institute for Food and
Health (ZIEL) at the Technical University of Munich (Freising, Bavaria, Germany).
3. Results
Alpha-diversity for the walnut and control diets is shown in Figure 2. Supplementing walnuts
in the diet did not significantly affect bacterial diversity measured by Shannons effective (walnut vs.
control 68.189 vs. 70.118, p = 0.3789) and Simpsons effective (33.138 vs. 35.405, p = 0.0861) counts.
According to this, there was no significant difference in evenness as well as in richness (179.326 vs.
179.393, p = 0.8522) for the walnut diet compared to the control diet.
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Figure 2. Within-sample alpha-diversity of sto l f j ct collected at the end of each diet phase.
Calculation of the alpha-diversity for each sa le ( l e: l t iet, red: control diet) for evaluating
species richness and diversity by using Shannon an Si sons effective indices. The diversity of a
microbial profile for a certain index is the number of different species related to abundance and richness.
By using generalized UniFrac distances considering the phylogenetic distance between OTUs,
a multidimensional distance matrix in a space of two dimensions has been visualized by MDS and
NMDS. Beta-diversity for walnut and control diet is shown as Principal Coordinate Analysis plot in
Figure 3a. Generalized UniFrac analysis demonstrated a clear clustering between the walnut and the
control group. MDS (metric and non-metric) indicated significant dissimilarities of approximately 5%
between walnut and control (p = 0.02).
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Figure 3. (a) Beta-diversity between walnut and control diet. Distinct clustering was observed between
the walnut and the control diet. By using generalized UniFrac distances considering the phylogenetic
distance between Operational Taxonomic Units, MDS plot indicates significant dissimilarities of
approximately 5% between walnut and control (p = 0.02). The multidimensional distance matrix
in a space of two dimensions is visualized as MDS plot. Subject’s clustering and coloring were
done according to the diet type. Each dot end indicates a sample position in the microbiota dataset
(blue: walnut diet, red: control diet). (b) Beta-diversity between three different diet types during
walnut consumption. Distinct clustering was observed between the diets. By using generalized
UniFrac distances considering the phylogenetic distance between Operational Taxonomic Units, MDS
plot indicates significant dissimilarities of approximately 5% between the different diets (p = 0.026).
The multidimensional distance matrix in a space of two dimensions is visualized as MDS plot. Subject’s
clustering and coloring were done according to the diet type. Each dot end indicates a sample position
in the microbiota dataset (red: d_1: carbohydrate restriction; green: d_2: fat restriction; blue: d_3: both).
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Generalized UniFrac analysis demonstrated a clear clustering between the different diet groups
during walnut consumption (Figure 3b). Again, MDS (metric and non-metric) indicated significant
dissimilarities of approximately 5% between the three diet types (p = 0.026).
Although walnut consumption shifted the predominant phyla from Firmicutes (61.2% after
walnut consumption vs. 63.9% after control) to Bacteroidetes (30.8% vs. 27.4% respectively), these
changes in abundance were not significant. Relative abundance was calculated from the relative
abundance of 16S rRNA gene sequences for each bacterial community by using the IMNGS platform.
The relative changes in OTUs for the bacterial phyla are shown in Figure 4a.
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Figure 4. (a) Relative abundance of the 4 dominating bacterial phyla between the walnut and the
control diet. Walnut consumption shifted the predominant phyla from Firmicutes (61.2% after walnut
consumption vs. 63.9% after control) to Bacteroidetes (30.8% vs. 27.4%). Relative abundance was
calculated from the relative abundance of 16S rRNA gene sequences for each bacterial community
by using the IMNGS platform. (b) Most abundant Operational Taxonomic Units for both walnut and
control phase at genus level. Significant different OTUs are marked with by using * and p-values.
p-values were calculated using a pairwise Fisher test.
The predominant bacteria at genus level (Figure 4b) were assigned to four different
phyla (Bacteroidetes, Firmicutes, Actinobacteria, Verrucomicrobia), five classes (Clostridia, Bacteroidia,
Actinobacteria, Verrucomicrobiae, Negativicutes), 5 orders (Clostridiales, Bacteroidales, Bifidobacteriales,
Verrucomicrobiales, Selenomonadales) and seven families (Ruminococcaceae, Bacteriodaceae, Lachnospiraceae,
Bifidobacteriaceae, Veillonellaceae, Rikenellaceae, Verrucomicrobiaceae).
After walnut consumption, significant shifts in the relative abundance of four members of
the phyla Firmicutes and in one member of the phyla Actinobacteria could be observed (Figure 5A).
A significant increase could be identified in two unknown species of the genus Ruminococcaceae spp.
(Clostridium Cluster IV) (p < 0.02) and in the species Bifidobacterium of the genus Bifidobacteriaceae spp.
(p < 0.02). In parallel, a significant decrease was observed in the relative abundance of two
Lachnospiraceae species (Clostridium Cluster XIV) (a) Anaerostipes (p < 0.01) and (b) Blautia (p = 0.04).
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Figure 5. (A) Serial-group-comparisons between walnut and control diet. Boxplots of all significant
comparisons. Since the data is not normally distributed, a non-parametric Kruskal–Wallis rank
sum test and a Fisher’s exact test has been used performed in Rhea. (a) OTU_41: Bacteria;
Actinobacteria; Actinobacteria; Bifidobacteriales; Bifidobacteriaceae; Bifidobacterium; (b) OTU_52: Bacteria;
Firmicutes; Clostridia; Clostridiales; Ruminococcaceae; (c) OTU_55: Bacteria; Firmicutes; Clostridia;
Clostridiales; Ruminococcaceae; (d) OTU_24: Bacteria; Firmicutes; Clostridia; Clostridiales; Lachnospiraceae;
Anaerostipes; (e) OTU_7: Bacteria; Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Blautia. (B)
Serial-group-comparisons between three different diets during walnut consumption. Boxplots of
all significant comparisons. Since the data is not normally distributed, a non-parametric Kruskal–Wallis
rank sum test and a pairwise Wilcoxon rank sum test has been used performed in Rhea. d_1:
carbohydrate replacement, d_2: fat replacement, d_3: both. (a) OTU_8: Bacteria; Firmicutes; Clostridia;
Clostridiales; Ruminococcaceae; Gemmiger; (b) OTU_9: Bacteria; Firmicutes; Clostridia; Clostridiales;
Lachnospiraceae; Fusicatenibacter; (c) OTU_4: Bacteria; Bacteroidetes; Bacteroidia; Bacteroidales; Bacteroidaceae;
Bacteroides.
Nutrients 2018, 10, 244 9 of 14
Since subjects were advised to reduce either fat or carbohydrates or both during walnut
consumption we also evaluated whether this affects microbiome. Comparing these three diet types
during walnut consumption revealed significant shifts in the relative abundance of two members
of the phyla Firmicutes and in one member of the phyla Bacteroidetes (Figure 5B). Over all groups,
a significant difference could be identified in a species of the genus Ruminococcaceae spp. (p < 0.01),
in one Lachnospiraceae species (p < 0.01) and in one species of the genus Bacteroidaceae spp. (p < 0.01).
Pairwise testing showed significant differences between the diet types.
4. Discussion
Daily consumption of 43 g walnuts resulted in significant changes in composition and diversity in
the gut microbiome by enhancing probiotic- and butyric acid-producing species in healthy individuals.
Obviously, diet is an important factor determining the composition of the gut microbiota.
In healthy adults, bacterial clusters within the phyla Bacteroidetes and Firmicutes usually dominate the
intestinal microbiota, whereas the proportions of Actinobacteria, Proteobacteria and Verrucomicrobia are
relatively small [17]. In animal models, the ratio of Bacteroidetes and Firmicutes is altered in response
to dietary changes [18]. However, although diet-induced shifts in the gut microbiota occur within a
short period of time (between 1–4 days after a change in diet), these changes have been shown to be
reversed just as rapidly [19,20]. Both genomic sequencings of bacterial rRNA from mice and humans
indicate that a high-fat diet promotes a reduction of Bacteroidetes, while a fat-restricted diet results in
the opposite scenario [21–23]. On the other hand, a high-fat Western-type diet in mice resulted in an
increased abundance of Firmicutes and a decrease in Bacteroidetes [19,24,25]. In contrast, no relationship
was observed between the ratio of Bacteroidetes and Firmicutes and diets low in carbohydrates [26].
Since sufficient and conclusive data from human feeding trials are missing, it is difficult to determine
the mechanisms by which walnuts, as part of a Western-type diet, may confer their modulating effects
on microbial distribution and changes in the ratio of the major bacterial phyla.
In our study, generalized UniFrac distances demonstrated a distinct clustering between the
walnut and the control groups as well as between the different diet types, demonstrating that
beta-diversity was altered by walnut consumption. MDS plotting indicated significant dissimilarities
of approximately 5% between bacterial clustering during the walnut and the control diets after eight
weeks of intervention (p = 0.02).
Overall, we identified five OTUs that were significantly associated with walnut consumption.
In particular, we found an enrichment of members of the genus Ruminococcaceae spp. and Bifidobacteriaceae
spp. Members of the genus Bifidobacterium spp. are proven to exert positive health benefits on their host
due to their probiotic properties. Bifidobacterium spp. are the normal inhabitants of a healthy human
gut, thus, a shift in their relative abundance and composition is one of the most frequent features
present in various gastrointestinal diseases including inflammatory bowel disease and colorectal
cancer [17,27–29]. Ruminococcaceae spp. are an abundant fraction of the human gastrointestinal
microbiota and are associated with several important metabolic functions within the Clostridiales
order (Clostridium sp. cluster IV) [1] due to the production of butyric acid. The short chain fatty
acid butyric acid is generated from fermentation of indigestible polysaccharides [30] and provides
energy for intestinal epithelial cells and contributes to host health by facilitating maintenance of colon
epithelial integrity and controlling inflammatory processes [31,32]. Our findings are consistent with
other studies investigating the effect of a walnut-enriched diet on the gut microbiome (consumption
of 42 g/day walnuts over a period of three weeks) indicating a significant (p < 0.05) increase in
the relative abundance within the Clostridiales order. [33]. Comparable results could be observed
in a trial in rats showing significantly greater species diversity after ten weeks on walnut diet by
increasing the abundance of probiotic-type bacteria including Lactobacillus spp., Ruminococcus spp. and
Roseburia spp. [34].
Besides the significant increase of members of Ruminococcaceae spp. and Bifidobacteriaceae spp., our
findings also showed a significant decrease of two representatives from the Lachnospiraceae family under
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walnut consumption. These butyric acid-producing microbes account for a great proportion of the
Clostridia class (Clostridium spp. Cluster XIVa) and are highly abundant within the human microbiome.
This contrasts with a trial evaluating the effect of walnut consumption on colon carcinogenesis in
mouse models which observed an increased abundance of Lachnospiraceae spp. during the walnut
diet [35]. However, the recommended daily serving of walnuts was higher and intervention period
longer. This discrepancy must be evaluated in further trials.
While eating walnuts, subjects were instructed to either reduce fat, carbohydrates or both. In a
subgroup analysis, we evaluated whether this also affects the gut microbiome. This analysis showed
significant differences in the relative abundance of three microbial representatives (Ruminococcaceae
spp., Lachnospiraceae sp., Bacteroidaceae spp.) between the different diet types, whereby no distinct
tendency could be observed after pairwise comparison. Thus, it is difficult to make a clear statement
about possible different effects as a consequence of macronutrient restriction. As previously mentioned,
our subjects did not fully comply with the recommended diet (i.e., substitution of carbohydrates or fat
or both for walnuts), indicating that subjects had a similar diet, despite different recommendations [9].
Since our study was designed as “free-living-study” it has to be kept in mind that there are probable
discrepancies in the intake of further phytonutrients (including flavonoids, carotenoids, polyphenols,
etc.) and dietary fiber intake, which may also induce changes in the gut microbiome (although we
did not observe any change in overall fiber intake). However, the study did not focus on changes in
these components, particularly since the study relied on self-reported food records making it difficult
to correctly estimate phytonutrient intake. The effect of these components can only be addressed by a
different study design.
The exact mechanisms by which walnuts may exert their beneficial health effects have not yet
been sufficiently investigated. The short chain fatty acid butyrate may beneficially affect metabolic
and inflammatory processes and, thus, obesity, diabetes and inflammatory bowel diseases [36,37].
However, only few feeding trials have examined the prebiotic effect of nuts, especially walnuts.
Thus, the exact mechanism by which they shift the relative abundance of microbial communities
and modulate fluctuations in the microflora composition in the gut in favor of butyrate-producing
microbes is unknown. Furthermore, non-digestible material from nuts, mainly polyphenols and
polysaccharides including dietary fiber seem to have a prebiotic effect by increasing Lactobacillus spp.
and Bifidobacterium spp. growth and fermentation of indigestible components to short-chain fatty acids
including butyrate [10,38,39] that may also alter activity of intestinal microbial enzymes [40].
In contrast to a higher beta-diversity, the change in alpha-diversity was not significantly different
between the walnut and the control groups. This indicates that, under walnut consumption, the gut
microbiota showed a slightly lower diversity than under the control diet; however, this difference was
not significant. Walnut consumption shifted (not significantly) the predominant phyla from Firmicutes
(61.2% after walnut consumption vs. 63.9% after control) to Bacteroidetes (30.8% vs. 27.4%) (Figure 4).
As mentioned above, the correlation between specific diets and shifts within the Firmicutes/Bacteroidetes
ratio is a matter of controversy [21–26]. Our data do not agree with the results of two previous animal
feeding studies demonstrating that walnuts significantly altered the relative abundance of these two
major gut bacterial phyla independent of the length of walnut consumption [34,41]. However, study
conditions are hardly comparable due to the different walnut serving sizes and varying study durations.
To date, no human feeding trials are available to discuss the effect of walnut consumption on the
Firmicutes/Bacteroidetes ratio.
As a first conclusion, our data indicate a correlation between walnut consumption and a shift
within the gut microbiome, suggesting that a regular supplementation might offer prebiotic and
probiotic benefits by improving the microbiome composition and diversity.
Recently, three papers described the prebiotic properties of other members of the tree nut family in
human clinical feeding trials. One study determined the effects of almond and pistachio consumption
on gut microbiota composition in humans. The effect of pistachios was much stronger than that
of almonds and resulted in an increase in potentially beneficial butyrate-producing bacteria in the
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phylum Firmicutes [42]. Comparable results have been demonstrated by another human feeding
trial with a similar initial hypothesis but over a much shorter intervention period of only 18 days.
The effect of pistachio consumption on gut microbiota composition was again much stronger compared
to that of almond consumption. It was concluded that almonds and especially pistachios can affect
the composition of the fecal bacterial microbiota [43]. In vitro and in vivo studies analyzed the
prebiotic effect and fermentation properties of raw and roasted almonds, as well as almond seed
and almond skin [40,44–47]. Both raw and roasted almonds showed potential prebiotic effects on
intestinal bacteria and metabolic activities, showing a stimulatory effect on fecal Lactobacillus spp., and
Bifidobacterium spp. [40]. Significant increases in the abundance of Bifidobacterium spp. and Lactobacillus
spp. could also be observed in fecal samples as a consequence of both raw almond and almond skin
supplementation [47].
Although our findings are only observational, the results indicate that nuts (especially walnuts)
may represent an important dietary supplement not only to positively influence blood lipids but
also to improve gut microbiome health. It is unclear if and how the changes in the microbiome
are linked to the observed changes in fasting lipid metabolism [9]. The study design and the
high variability in the observed changes in the microbiome preclude any valid conclusions at
this point. Interestingly, there are only very few studies investigating the effect of statins on gut
bacteria. It has been hypothesized that gut bacteria may cause inherent differences in the way subjects
metabolize and benefit from therapeutic agents due to higher levels of bacterial-derived bile acids [48].
Furthermore, gut microbiota analysis in mice treated with hypolipidemic drugs revealed a modification
in composition in favor of probiotic-type bacteria from Lactobacillus spp. [49]. However, the exact
mechanisms by which cholesterol-lowering substances may interact with the human gut microbiome
have not been sufficiently investigated. Another interesting aspect that should be considered for further
investigations is the finding that certain metabolites strongly correlate with microbial community
structures which would allow gaining insights into microbiome–host interactions, also in context of
certain diseases and therapeutic interventions [50,51]. The analysis of metabolic fingerprints might be
useful to understand how microbial structures are influenced by regular walnut consumption.
More interventional nutritional studies might be required to quantify the underlying mechanisms
by which walnut components influence microbiome composition and how the abundance of
butyrate-producing bacteria is increased. Furthermore, further evaluation regarding whether these
observed changes are preserved during longer walnut consumption is required.
5. Conclusions
Current study results show a shift within the composition of microbial communities in the human
gut under nut consumption. This shift is characterized by an increase in the relative abundance
of potentially beneficial butyrate-producing bacteria. In our study, we showed that daily intake of
43 g walnuts over eight weeks significantly affected the gut microbiome by enhancing probiotic-
and butyric acid-producing bacteria in healthy individuals. It is unclear whether these changes are
preserved during longer walnut supplementation and how these changes are associated with the
observed changes in lipid metabolism. More human intervention trials investigating different servings
of nuts over a longer time period might be useful to further evaluate the prebiotic properties of
walnut consumption.
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